SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-322588
Filing Date
2018-11-08
Accepted
2018-11-08 16:23:04
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d632002d10q.htm 10-Q 294278
2 EX-31.1 d632002dex311.htm EX-31.1 10800
3 EX-31.2 d632002dex312.htm EX-31.2 10785
4 EX-32.1 d632002dex321.htm EX-32.1 5473
11 GRAPHIC g632002g95i66.jpg GRAPHIC 91833
  Complete submission text file 0001193125-18-322588.txt   2632487

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT meip-20180930.xml EX-101.INS 333325
6 XBRL TAXONOMY EXTENSION SCHEMA meip-20180930.xsd EX-101.SCH 36040
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20180930_cal.xml EX-101.CAL 38264
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20180930_def.xml EX-101.DEF 220547
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20180930_lab.xml EX-101.LAB 310104
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20180930_pre.xml EX-101.PRE 258866
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 181169996
SIC: 2834 Pharmaceutical Preparations